Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

554
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
554
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Duck hepatitis B virus integrations in LMH chicken hepatoma cells: identification and characterization of new episomally derived integrations.

Journal of virology·1995
Same author

Automated assay of oxygen radical absorbance capacity with the COBAS FARA II.

Clinical chemistry·1995
Same author

The Claviceps purpurea gene encoding dimethylallyltryptophan synthase, the committed step for ergot alkaloid biosynthesis.

Biochemical and biophysical research communications·1995
Same author

Direct effects of smooth muscle relaxation and contraction on in vivo human brachial artery elastic properties.

Circulation research·1995
Same author

Yeast two-hybrid system demonstrates that estrogen receptor dimerization is ligand-dependent in vivo.

The Journal of biological chemistry·1995
Same author

Synthesis, characterization and antibacterial activity of novel Fe(III), Co(II), and Zn(II) complexes with norfloxacin.

Journal of inorganic biochemistry·1995

Related Experiment Video

Updated: Jul 16, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.0K

Lymph node targeting for immunotherapy.

Y Wang1,2, H Wang1,3,4,5,6,7,8

  • 1Department of Materials Science and Engineering, University of Illinois at Urbana-Champaign, Urbana, USA.

Immuno-Oncology Technology
|September 18, 2023
PubMed
Summary

This review explores advanced lymph node-targeting technologies for enhancing immunotherapy. These strategies aim to improve immune cell responses for better treatment of diseases like cancer.

Keywords:
immune responseimmunotherapylymph node targetingmaterialsvaccine

More Related Videos

Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

14.5K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.1K

Related Experiment Videos

Last Updated: Jul 16, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
07:45

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis

Published on: January 26, 2024

2.0K
Intra-lymph Node Injection of Biodegradable Polymer Particles
09:06

Intra-lymph Node Injection of Biodegradable Polymer Particles

Published on: January 2, 2014

14.5K
Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
07:04

Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation

Published on: September 16, 2018

10.1K

Area of Science:

  • Immunology
  • Biotechnology
  • Drug Delivery

Background:

  • Immunotherapy has advanced significantly, with successes in cancer treatment via checkpoint blockades, CAR T-cell therapy, and vaccines.
  • Effective immunotherapy relies on potent, persistent immune responses, driven by antigen-presenting cells priming T and B cells in lymph nodes.
  • Direct delivery of immunomodulators to lymph nodes is crucial for potent immune responses.

Purpose of the Study:

  • To provide a comprehensive overview of lymph node-targeting technologies for immunotherapy.
  • To discuss the mechanisms and advantages of various passive and active targeting strategies.
  • To highlight advancements in facilitating immunomodulatory agent delivery to immune cells within lymph nodes.

Main Methods:

  • Review of existing literature on lymph node-targeting technologies.
  • Analysis of strategies for delivering immunomodulatory agents to lymph nodes.
  • Discussion of intranodal injection limitations and alternative targeting approaches.

Main Results:

  • Multiple passive and active technologies have been developed to overcome intranodal injection challenges.
  • These technologies aim to improve the delivery of immunomodulatory agents to antigen-presenting cells and lymphocytes in lymph nodes.
  • The review details the mechanisms and merits of diverse lymph node-targeting approaches.

Conclusions:

  • Lymph node-targeting technologies are essential for optimizing immunotherapy efficacy.
  • Advancements in targeting strategies enhance the priming of antigen-specific T and B cells.
  • Further development in this field holds promise for improved therapeutic outcomes in various diseases.